Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Ying-Ju Ou"'
Autor:
Ying-Ju Ou, 歐盈如
106
Background: Bisphosphonates (BPs) are commonly used for osteo- porosis therapy as well as bone loss and skeletal-related complications. Numerous of preclinical studies have described that BPs may have anti-tumor effects. In 2009, the first A
Background: Bisphosphonates (BPs) are commonly used for osteo- porosis therapy as well as bone loss and skeletal-related complications. Numerous of preclinical studies have described that BPs may have anti-tumor effects. In 2009, the first A
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/2cgvq3
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 13; Pages: 4435
(1) Background: We aimed to explore the associations between menopause, postmenopausal hormone therapy, and metabolic syndrome in a large community-based group of Asian women. (2) Methods: This is a cross-sectional study in which we enrolled women ag
Publikováno v:
Pharmacoepidemiology and Drug Safety. 26:1286-1295
To summarize current evidence of the association of bisphosphonate use with breast cancer risk, we used a systematic review and meta-analysis of observational studies to explore this issue.A comprehensive search was conducted on PubMed, EMBASE, and t
Publikováno v:
Pharmacoepidemiology and Drug Safety. 25:1107-1115
Background The association of bisphosphonate use and the risk of endometrial cancer is still unclear. No meta-analysis was conducted to review the evidence concerning this topic. Methods Relevant studies were identified through PubMed and EMBASE and
Publikováno v:
Pharmacoepidemiology and drug safety. 25(10)
The association of bisphosphonate use and the risk of endometrial cancer is still unclear. No meta-analysis was conducted to review the evidence concerning this topic.Relevant studies were identified through PubMed and EMBASE and the Cochrane Library
Publikováno v:
Analytica chimica acta. 611(1)
Docosanoic (C22), tetracosanoic (C24) and hexacosanoic (C26) acids are saturated very-long-chain fatty acids (VLCFA) present at trace levels in biosamples. VLCFA can be used as potential biomarkers for the diagnosis of hereditary diseases such as X-l